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INTRODUCTION
Adenocarcinoma of the colon and rectum is one among most common 
site of new cancer cases and deaths in both men (following prostate and 
lung/bronchus) and women (following breast, cervix and lung/bronchus).The 
lifetime risk for developing invasive colorectal cancer increases with age, 
with more than 90% of new cases being diagnosed in patients older than 
50years.
Colorectal  cancer  occurs  in  hereditary,  sporadic,  or  familial  forms. 
Hereditary forms of colorectal cancer have been extensively described and 
are characterized by family history, young age  at onset, and the presence of 
other  specific tumors and defects.  Familial  adenomatous polyposis (FAP) 
and  hereditary  nonpolyposis  colorectal  cancer  (HNPCC)  have  been  the 
subject of many recent investigations that have provided significant insights 
into the pathogenesis of colorectal cancer.
Sporadic  colorectal  cancer occurs in  the absence of  family  history, 
generally affects an older population (60 to 80 years of age) ,and usually 
presents as an isolated colon or rectal lesion. Genetic mutations associated 
with the cancer are limited to the tumor itself, unlike hereditary disease, in 
which the specific mutation is present in all cells of the affected individual. 
Nevertheless,  the  genetic  of  colorectal  cancer  initiation  and  progression 
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proceed along very similar pathway in both hereditary and sporadic forms of 
the disease.
Cancers arising in the distal 15cms of the large bowel share many of 
the  genetic,  biologic,  and  morphologic  characteristics  of  colon  cancers. 
However, the unique anatomy of the rectum, with its retroperitoneal location 
in  the  narrow  pelvis  and  proximity  to  the  urogenital  organs,  autonomic 
nerves,  and  anal  sphincters,  make  surgical  access  relatively  difficult.  In 
addition,  precise  dissection  in  appropriate  anatomic  planes  is  essential 
because  dissection  medial  to  the  endopelvic  fascia  in  vesting  the 
mesorectum may doom the patient to local recurrence of the disease, and 
dissection laterally to the avascular anatomic space risks injury to the mixed 
autonomic nerve, causing impotence in men and bladder dysfunction in both 
sexes.
Furthermore, the biologic properties of the rectum, combined with its 
anatomic  distance  from the  small  intestine  afforded  by  it  retroperitoneal 
pelvic location, provides an opportunity for treatment by radiation therapy.
The treatment of colorectal cancer has changed significantly during 
the past 20 years, and there is considerable controversy today concerning the 
precise role of surgery, radiation therapy, and chemotherapy, and the ideal 
timing of each modality with relation to the others. Although information 
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from clinical trials has provided data supporting the multimodality treatment 
of rectal cancer, the criteria for patient selection remains controversial.
According  to  recent  analysis  preoperative  radiation  is  superior  to 
postoperative radiation.
The best course of neoadjuvant treatment has not yet been determined.
Neoadjuvant chemoradiation may increase the ability of the surgeon 
to  preserve  continence  by  down-staging  the  cancer,  in  some  instance 
shrinking the size of the tumor to permit the achievement of a cancer-free 
margin at the distal extent of the resection, when a clear margin that would 
permit an anastomosis could not be achieved without such shrinkage.
Increased  number  of  colo-rectal  surgeons  has  shown  improved 
outcomes,evidencing that “the surgeon”has to be listed as a “risk-factor”. 
Finally, to still improve surgical outcomes a further effort  was made, 
since twenty years to now, by employing adjuvant therapies - Radiotherapy 
(RT) and Chemotherapy (CT) - resulting in significant  reduction of local 
recurrence  rates,  however  partially  improving  mortality  but  exposing 
patients to high morbidity.
Later  on,  a  continuous  change  of  adjuvant  approach  has  been 
developed: in short,  adjuvant therapy has been replaced, step by step, by 
neo-adjuvant approach.
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AIM OF THE STUDY
To  evaluate  the  usefulness  of  Neoadjuvant  chemo-radiotherapy  in 
colorectal carcinoma.
To  improve  the  rates  of  surgeries  feasible  following  neoadjuvant 
therapy
9
ANATOMY OF COLON & RECTUM
The Colon & Rectum constitutes a tube of variable diameter about 
150cm in length. The terminal ileum empties into the caecum through the 
ileocaecal valve.
The caecum is a capacious sac like segment of the proximal colon 
with an average diameter of 7.5cm & 10cm in length.
The appendix extends from caecum about 3cm below the ileocaecal 
valve as a blind ending elongated tube of 8-10cm length.
The ascending colon about 15cm in length runs upwards towards the 
liver on right side, like the descending colon, the posterior surface is fixed 
against  the  retroperitoneum,  where  lateral  &  anterior  surfaces  are  true 
intraperitoneal structures.
The Transverse colon is about 45cm in length, hanging between fixed 
portions  at  the  hepatic  &  splenic  flexures,  it  is  completely  invested  in 
visceral peritoneum.
The  nephrocolic  ligament  secures  the  hepatic  flexure  &  directly 
overlies the right kidney, duodenum & portahepatis.
The phrenocolic ligament lies ventral to the spleen & fixes the splenic 
flexure in left upper quadrant. The angle of slenic flexure is higher, more 
acute & more deeply situated the  heptic flexure. 
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The  superior  aspect  of  transverse  colon  is  attached  to  Greater 
Omentum.
The  descending  colon  lies  ventral  to  the  left  kidney  and  extends 
downwards from splenic flexure for about 25cm. It is smaller in diameter 
than  Ascending colon.
At  the  pelvic  brim,  there  is  transition  from  descending  colon  to 
Sigmoid colon.
The Sigmoid colon varies in from 15 to 50cm(avg.38cm) in length 
and is very mobile. The mesosigmoid is frequently attached to the left pelvic 
sidewalls.
The rectum is 12 to 15cm in length and lacks taenia coli and occupies 
the  curve  of  the  sacrum  in  true  pelvis  and  posterior  surface  is  almost 
completely extraperitoneal.
The Rectum posssesses three involution or folds known as valves of 
Houston. 
The middle fold to left & proximal and distal valve fold to right.
The posterior aspect of rectum is invested with a thick closely applied 
mesorectum.
A thin  layer  of  investing  fascia  propria  coats  the  mesorectum  & 
distincts from the presacral fascia.  
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Pararectal  fascia;  the  endopelvic  fascia  is  a  thick  layer  of  parietal 
peritoneum that lines the walls & floor of the pelvis.
Prescral fascia- portion closely applied to the peritoneum of anterior 
sacrum.
Fascia  propria-  thin  condensation  of  endopelvic  fascia  &  forms  a 
envelop  around  the  mesorectum  and  distally  forms  the  lateral  sacral 
ligaments containing the middle rectal artery.
Waldeyers fascia- rectosacral fascia, thick condensation of endopelvic 
fascia, connects the presaral fascia to fascia propria.
Dissection  between  fascia  propria  &  presacral  fascia  allows  the 
principles of surgical oncology and minimizes the risk for vascular or neural 
injuries.
Arterial supply:
Superior mesenteric artery through,   
• Ileo colic artery
• Right colic artery
• middle colic artery
       Inferior mesenteric artery through,
• left colic artery
• sigmoid arteries
• superior rectal arteries.
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      Internal iliac artery through,
• middle rectal & inferior rectal arteries.
• Venous drainage of colon & Rectum mirror the arterial supply.
• SMV – right & proximal transverse colon.
• IMV -   distal transverse, descending, sigmoid and most of rectum 
which drains into splenic vein to the left of Aorta.
• LYMPHATIC drainage : arranged in four tiers
First tier     - epicolic, adjacent to colon 
Second tier- paracolic, along marginal vessels
Third tier    -  along the named branches.
     Fourth tier  - Principal nodes along SMA, IMA.
Lymph node invasion by metastatic  cancer  is  important  prognostic 
factor for colorectal ca. Accurate pathologic assessment of LN  is essential 
for accurate staging. 
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Nerve supply:
Preganglionic sympathetic from T10-T12 to right & transverse colon.
Parasympathetic from right vagus to right & transverse colon.
Sympathetic supply to left colon & rectum from L1-L3.
The lower rectum from pelvic plexus.
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EPIDEMIOLOGY
The incidence of large bowel cancer varies between and within countries, which 
strongly suggests an environmental cause. The incidence is almost equal between 
the sexes, with some difference in risk ratio for cancers of different parts of the 
large bowel, Rectal cancers are twice as common among men but for the rest of 
the large bowel the male : female ratio is about 8 :1 with right — sided cancers  
even more common in women.
The incidence of large bowel cancer is high in the urban ‘Western’ world but is 
rare  is  Asia,  Africa  and  parts  of  south  America.  There  are  also  apparent 
geographical differences in incidence with in countries.
Approximate incidence per 1,00,000 people
Africa 2
Asia 15
South America 15
West Europe 40
USA 35
For example the incidence is higher in Scotland than in England, and higher in 
Northern Italy and the northern United States than in the southern parts of the 
same countries. The minor changes in incidence of coronary heart disease. This 
north / south divide is not a fundamental association with latitude.
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PATHOPHYSIOLOGY 
GENETIC FACTORS:
The epidemiological  evidence so far  suggests  that  environmental  factors 
predominate in the genesis of large bowel cancer within populations, but it would 
be  surprising  if  inherited  genetic  factors  did  not  play  a  numerically  small  yet 
important role in the formation of colorectal cancers.
Colorectal cancer, in common with all tumours, show qualitative and often 
quantitative changes in the chromosomes when compared to normal cell. Many 
colon  cell  line  show  chromosome  distortion,  with  trisomy  of  some  or  many 
chromosomes, sometimes to the point aneuploidy. There is evidence to suggest 
that  tumours  with  a  poor  bizarre  chromosomal  configuration  with  a  greater 
proportion of aneuploid cells.
Some genes or gene deletions may also provide some protection against the 
development of cancer, in much the same way that possession of the recessive 
sickle  — cell  or  thalassaemia genes  protect  against  malaria  to  some extent.  It 
seems that the cystic fibrosis gene deletion, Delta F508 condon, which is carried 
by about 1 in 27 people, may protect against colorectal cancer and some other 
tumours.
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The incidence of bowel cancer among the Finns and the Eskimos is low, 
suggesting the differences are more likely to be due to differences in social and 
dietary  behaviour,  perhaps  induced by climatic  changes.  The incidence  is  also 
different in cultural groups within countries for example, 18/100000 white South 
Africans  have  colorectal  cancer  which  the  incidence  amongst  there  black 
compatriots  is  about  6/100  000.  The  proportions  in  New Zealand  whites  and 
Maoris are similarly 3:1. though the incidence is about twice that of South Africa.
The peak incidence for the disease is in the seventh decade, some 5 years 
later than the corresponding peak for colonic adenomatous polyps, which suggests 
that prolonged exposure to weak environmental carcinogens is necessary to induce 
tumours and that most, possibly all, pass through the benign phase before turning 
malignant.
The  epidemiology  of  proximal  and  distal  rectal  cancer  is  not  the  same 
worldwide. The ratio of rectal to colonic cancer varies from 1:3 in white South 
African males to 1:1 in Finns and Maoris.
Colo Rectal cancer Genetics: 
The filed of colorectal cancer genetics was revolutionized in 1988 by the 
description  of  the  Genetic  changer  involved  in  the  progression  of  a  benign 
adenomatous polyp to invasive carcinoma.
17
The  Fearon  –  vogelstein  adenoma  –  carcinoma  multistep  model  of 
colorectal neoplasia represents one of the best known models of carcinogenesis.
APC     K-RAS DCC
Normal-colonic Dysplastic aberrant     Early      Intermediate      Late
Epithelium crypt Foci adenoma   adenoma      adenoma
Other changes?
Metastasis Carcinoma P53
ADENOMAS AND PAPILLOMAS:
According to Dukes there exists a close relationship between benign and 
malignant epithelial tumours of the intestine. The following observations are in 
favour of above statement.
1. It has been frequently observed that patient with adenoma or papilloma 
of colon and rectum have developed carcinoma.
2.  Often there exists  a small  focus of carcinoma in a tumors which has 
histological characteristics of adenoma, and villous papillomas in its greater 
part.
3. On careful search a surviving position of a benign tumour may be seen at 
the edge of a frank carcinoma.
The  risk  of  malignant  transformation  depends  on  the  characteristic  of  the 
adenoma. Nearly 5% of the tubular adenoma, 22.5% of tubulovillous polyps and 
40% of villous adenoma contain carcinoma. When adenoma are less than 2cm 
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diameter only 1% of tubular polyps contain carcinomas as compared with 3.5% 
papillovillous and 10% villous adenoma. In tumour over 2cm in size carcinoma is 
present in 35% of tubular adenoma and over 50% of villous tumours.
CANCER PROMOTORS AND INHIBITORS:
PROMOTORS
Genetic Familial adenomatous Polyposis
Hereditary Non — polyposis Colonic Cancer
Peutz — Jegher’s syndrome
Juvenile Polyposis syndrome
Diet High fat diet 
Bile acids
Bacteria Nuclear Dehydrogenases Producing Clostridia
Operations Cholecystectomy’
Gastric surgery
Ureterosigmoidostomy
Irradiation Ulcerative colitis
Diseases Crohns diseases
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INHIBITORS
INHIBITORS MECHANISM OF ACTION
Calcium Increase  cellular  adhesion;  decreases 
cellular proliferation
Vitamin D Retards in vitro growth of human cancer 
cells, lowers level of ornithine
decarboxylase in rates
Vitamin C Deficiency  increases  colon 
carcinogenesis  by  alatonin  A: 
administration may suppress
experimental colon tumours.
Vitamin E Free radical  scavengers shown both to 
inhibit  and  to  promote  colon  tumor 
growth in carcinogenesis models.
Daily sulfide (Garlic Compound)
Allyl methyl trisulfide
(garlic compound)
Inhibit  carcinogen  induced  nuclear 
injury.
Increases activity of glutathione 
S-transferase,  which  may  inactivate 
carcinogens
IRRADIATION
X — rays are  important  mutagens.  It  is  therefore  hardly  surprising that 
intracavitary  irradiation  in  the  treatment  of  carcinoma  of  the  cervix  uteri  is 
associated with a small  increased incidence of rectal cancer within the field of 
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irradiation. These cancers appear some 5 to 15 years later.
INFLAMMATORY BOWEL DISEASE
Ulcerative colitis, for a long time, have been known to increase the risk of 
colorectal cancer. The risk increases almost exponential with some 1 0 years after 
the onset of the disease, particularly in patients who have total colitis, those with a 
severe first attack, those who develop the disease in childhood, and those patients 
whose disease follows a relapsing course. Patients with mild distal colitis have no 
greater risk of developing cancer rectum than the normal population while patients 
with severe long standing disease have a 1 in 2 change of developing cancer after  
30 years. Areas of dysplasia may be scattered throughout the colon, and rectum 
which explains the greater likelihood of multiple cancers among those with colitis. 
The tumour are seldom exophytic but usually flat and infiltrating, which makes 
diagnosis  more  difficult.  The  prognosis  of  these  colitis  cancers  was  originally 
thought  to  be  particularly  poor  but  more  recent  data  suggests  that  there  is  no 
difference  in  prognosis  of  these  colitis  cancers  among  those  with  colitis.  The 
tumours  are  seldom  exophytic  but  usually  flat  and  infiltrating,  which  makes 
diagnosis more difficult. The progression of theses colitis to cancers was originally 
thought to be particularly poor but more recent data suggests that stage, there is no 
difference  in  prognosis  compared  to  sporadic  cancers.  Crohn’s  colitis  is  also 
associated with an increased risk of cancer in the disease segment as well as in 
other area of the digestive tract. The risk is, however less than that associated with 
severe ulcerative colitis.
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IMMUNO SUPPRESSION:
Long — term immunosuppression, either for the prevention of transplant 
rejection  or  as  a  consequence  of  HIV  infection,  predisposes  to  cancer. 
Lymphomas,  which  may  affect  the  colon  and  rectum  in  immunosuppressed 
transplant patients. Small cell carcinomas of the colon and rectum which are rare 
in  the  otherwise  healthy  population  have  been  reported  in  AIDS  patients. 
However,  there  appears  to  be  no  association  between  adenocarcinomas  of  the 
colon,  rectum  and  immunosupppression.  Neoplasms  themselves  induce  some 
degree of immune suppression, either directly through products of the malignant 
cells or indirectly through malnutrition and cachexia. Suppression of this immune 
response is probably mediated by secretion of soluble suppressor factors such as 
the  retroviral  protein  pl5E  which  is  also  responsible  in  a  number  of  tumours 
including colorectal cancers.
PATHOLOGY, STAGING AND PROGNOSIS
Colorectal cancers, in common with most epithelial tumours, are polyclonal 
with  clones  of  cells  exhibiting  differing  degrees  of  ‘Malignancy’.  The  more 
undifferentiated  or  more  ‘Malignant’  clones  are  more  likely  to  spread  and 
metastasize.  A tumour’s  biological  behaviour  is  the  main  determinant  of  the 
tumour’s propensity to spread locally and to metastasize and, therefore, indicates 
the ultimate prognosis. This is reflected to some extent by the Histopathological 
features of a cancer. Tumour secondaries, which are often derived from selected 
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clones of a polyclonal primary, are likely to behave in the same way as the primaiy 
tumour and will generally be more malignant.
Tumour biology is very much reflected by the stage of the disease. It is no 
surprise that there is a significant inverse relation between the length of history 
and the stage of the disease at diagnosis. Quicker growing tumours usually present 
with  a  short  history  and  are  advanced  at  the  time  of  treatment.  Although  the 
clinical and pathological stage is a ‘snapshot’ in the life of a tumour, it provides 
the  most  accurate  prognostic  index;  this  may  be  refined  further  by  the 
Histopathological  features.  Several  staging  methods  are  in  use  throughout  the 
world, and each has its own strengths and weaknesses. The most commonly used 
are  the  Duke’s  classification  and  derivations  of  it,  or  the  Union  international 
Cancer center (UICC) TNM classification. The former has the advantages of great 
simplicity  but  considerable  disadvantages  from  lack  of  precision.  It  does  not 
reflect accurately the depth of tumour penetration, the extent of spread outside the 
bowel, the number of lymph nodes affected by tumour or the presence or absence 
of metastasis, all of which have an important bearing upon prognosis. Derivations 
such  as  the  Astler  —  Coller  and  Australian  classifications  refine  the  Duke’s 
staging but  do  not  provide  the  flexibility  of  the  TNM method,  which  enables 
useful division into subsets without being unduly complex. It  is therefore most 
appropriate that surgeons adopt the TNM classification as a suitable international 
standard.
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Staging gives information about prognosis in general, but particularly indicates the 
probability  of  occult  hepatic  metastases.  Which  is  the  major  factor  affecting 
survival.  Patients  with Dukes C tumour are more likely to have occult  hepatic 
metastasis.  Occult  hepatic  metastases  account  for  the  majority  of  deaths  from 
colorectal cancer while only about 20% of patients die from local spread of the 
disease, which is also reflected, in the clinical stage.
STAGING OF TUMOUR:
1. Dukes classified carcinoma of the rectum into three stages.
Stage A  The growth is limited to the rectal wall (15%) prognosis excellent
Stage B  The growth has extended to the extra rectal tissues but no metastasis 
to the regional lymph modes (35%) prognosis reasonable. 
Stage C There  are  secondary  deposits  in  the  regional  lymph nodes  (50%) 
prognosis bad.
ASTLER AND COLLER (1954):
Has made this classification more accurately interms of 
Stage A : Lesion limited to mucosa.
Stage Bl : Lesion penetrating muscularis propia but not through it.
Stage B2 : Lesion penetrating muscularis and extending into the serosa. 
Negative lymph nodes.
Stage Cl : Lesion involved all layers of bowel wall except serosa 
positive lymph nodes
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Stage C2 : Lesion involves all layers of the bowel walls
Stage D : Distant Metastasis
AJCC TNM staging system for colorectal cancer
T – Primary Tumor
Tx  - Primary tumor cannot be assessed
To – No evidence of primary tumor
Tis – Carcinoma in Situ
T1 – Tumor invades submucosa
T2 – Tumor invades muscularis Propria
T3  –  Tumor  invades  through  muscularis  propria  into  subserosa  or  into  non 
peritonealized pericolic or perirectal tissues.
T4 – Tumor directly invades other organs or perforates visceral peritoneum.
N- Regional Lymph Nodes
Nx – Regional Lymph Node cannot be assessed
N0 – No regional Lymph Node metastasis
N1 – Metastasis in 1-3 regional Lymph Nodes
N2 – Metastasis in 4 or more regional Lymph Nodes
M – Distant metastasis
Mx – Distant metastasis cannot be assessed 
M0 – No distant metastasis
M1 – Distant Metastasis
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Stage wise comparison 
STAGE T N M Dukes MAC
O Tis No Mo
I T1 No Mo A A1
T2 No Mo A B1
IIA T3 No Mo B B2
IIB T4 No Mo B B3
IIIA T1-T2 N1 MO C C1
IIIB T3-T4 N1 MO C C2/C3
IIIC Any T N2 MO C C1/C2/C3
IV Any T Any N M1 D
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MACROSCOPIC APPEARNACE:
Macroscopically cancer rectum may be
1. Proliferative
2. Ulcerative
3. Annular
4. Diffusely infiltrating
5. Colloid
1. The  proliferative  type  is  the  most  frequently  occurring  one.  It  forms  a 
fleshy bulky polypoid mass that bulges into the lumen of the bowel. It is a 
malignant adenoma of slow growth and of low order of malignancy and 
arises form the wall of the gut form a wide base. The proliferated  growths 
are usually well differentiated adenocarcinoma. 
2. Ulcerative growth present as a typical malignant lesion with raised irregular 
everted edges and a sloughing floor. It has tendency to infiltrate the bowel 
wall.
3. The annular type of growths is seen typically in the upper /3 of the rectum. 
Small densely hard slow growing tumour that do not project into the rectum 
apparently  but  tends  to  encircle  the  gut  wall  and  thus  obstructing  the 
passage of solid faecal matter. 
4. Diffusely  infiltrating  carcinoma  colon  &  rectum.  It  proceeds  a  diffuse 
thickening of the intestinal wall usually extending at least 5 to 8 mm and 
for the most part  covered with mucosa but there is usually ulceration at 
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some point. This form of carcinoma is some times found as an extension of 
one, of the other gross type of the growth. It is also not infrequently the 
type  of  the  growth.  It  is  also  infrequently  the  type  of  carcinoma  that 
develops in ulcerative colitis. 
5. Colloid carcinoma usually forms a bulky growth with very suggestive of 
gelatinous  appearance.  There  may  not  be  extensive  ulceration  and 
infiltration.
HISTOPATHOLOGICAL GRADING AND TYPING:
Grading  depending  upon  subjective  interpretation  of  the  degree  of 
differentiation  at  histological  examination.  Various  grading  systems  have  been 
proposed, but grading into two broad groups, low or average grade tumours which 
are well to moderately differentiated and high grade or undifferentiated induces 
the  variation  between  observers  while  at  the  same  time  providing  useful 
prognostic information.  Patients  with high grade cancers have worse prognosis 
when compared with patients with well differentiated lesions after taking account 
of the tumour stage.
Typing  on  the  other  hand reflects  the  cellular  characteristics.  Mucinous 
signet  cell  and  small  cell  tumour  are  the  variants  of  the  more  common 
adenocarcinoma and the frankly undifferentiated cancers again typing may give 
some  cell  tumour  have  a  prognostic  information.  Signet  cell  and  small  cells. 
Tumours have a worse prognosis than adenocarcinoma. While mucinous lesions 
tend to recur locally.  Both of these tumours are however more common in the 
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anus. Other varieties are carcinoid and Leiomyosarcoma.
Histological features such as vascular, lymphatic or peri neural invasion are 
prognostically unfavourable.  By contrast  lymphocytic infiltration of the tumour 
and  a  histolytic  reaction  in  the  regional  lymph  nodes  are  minor  favourable 
prognostic features.
CLINICAL FEATURES
Carcinoma  of  the  rectum is  not  uncommon  early  in  life  and  when  the 
disease commences in youth in spite of radical treatment,  death usually results 
within a year. Usually the early symptoms are so slight that the patient does not 
seek advice for 6 months or more.
COMMON
o Abdominal pain
o Bleeding
o Unexplained anemia
o Change in bowel habits
UNCOMMON
• Acute 
o Obstruction
o Perforation
o Abdominal mass
o Metastatic disease
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BLEEDING:
Bleeding  is  the  earliest  and  most  constant  symptom.  There  is  nothing 
characteristic about the time at which it occurs neither is the colour or the amount 
of blood distinctive. Often the bleeding is slight in amount, and occurs at the end 
of defecation or is noticed because it has stained underclothing.
Indeed more often then not the bleeding in every respect simulated that of 
internal hemorrhoids and it is lamentable that, in spite of the repeated exhortation, 
the patient’s doctor sometimes fails to examine the rectum but prescribe a salve 
while the growth advances to inoperability.
SENSE OF INCOMPLETE DEFAECATION:
The patient has his bowel open but feels that there are more faeces to be 
passed. This is a very important early symptoms and is almost invariably present 
in tumours of the lower half of the rectum. The patient may endeavour to empty 
the rectum several times a day (spurious diarrhea), often with the passage of Hams 
and a little bloodstained mucus (blood slime).
ALTERATION IN BOWEL HABIT:
Alteration in bowel Habit is the next most frequent symptom. The patients 
may find it necessary to start taking an aperients, or to supplement his usual doses 
and as a result a tendency towards diarrhea ensues. A Patient who has to get up 
before the accustomed hour in order to defecate and one who passes blood and 
mucus in addition to faeces (early morning bloody diarrhoea) is usually found to 
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be suffering from carcinoma of the rectum. Usually it is the patient with an annular 
carcinoma at the pelvirectal junction who suffers with increasing constipation, and 
the one with a growth in the ampulla of the rectum with early morning diarrhoea.
Identification of surface tumour antigens such as carcinoembryonic antigen, 
oncogene expression and DNA ploidy potential refinement but these are not yet in 
routine use.
PROGNOSIS
Stage remains the most important indicator of prognosis. The prognosis of 
patients with adequately treated Stage IV cancers is little different from that of an 
otherwise healthy population of the same age. 95 to 100% live 5 years of more 
after resection. Patients with cancer spread through the serosa only have a 40 to 
60% chance of living 5 years, although the prognosis is more favourable if the 
tumour is only just through the serosa and is correspondingly worse if adjacent 
structures are invaded. Lymph node metastasis further adversely affects prognosis 
with only about 30% of patients surviving 5 years. Sub classification is useful. The 
survival  curve  of  patients  with  colon and rectal  cancer  treated  by  resection  is 
curvilinear, reaching a nearly flat plateau.
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PAIN:
Pain  is  a  late  symptom  but  pain  of  a  colicky  character  accompanies 
advanced growths of the recto sigmoid and is due to some degree of intestinal 
obstruction. When a deep carcinomatous ulcer of the rectum invades the prostate 
or bladder,  there is  severe pain.  Pain in the back,  or sciatica,  occurs when the 
growth invades the sacral plexus. Weight loss is suggestive of hepatic metastases. 
When the peritoneum has become studded with secondaiy deposits ascites results.
MANIFESTATIONS OF ADVANCED DISEASE
Locally advanced - Dysuria, frequency 
Rectal cancers – Neuropathic pain syndrome
Females - RVF (Recto Vaginal Fistual)
Metastatic Liver metastasis - - Jaundice Hepatomegaly
Supraclavicular node enlargement
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PRE-OPERATIVE EVALUATION
Preoperative evaluation should include the following
CARCINOEMBRYONIC ANTIGEN:
First described by (Gold and Freedman) in 1965, carcinoembiyonic antigen is a 
foetal protein present in tumours of the gastrointestinal tract and in foetal tissue 
but  not  in  adult  intestinal  tissue.  Plasma  concentration  of  carcinoembryonic 
antigen may be elevated in patients with colorectal carcinoma but they may also be 
normal.
In addition, elevated plasma concentrations of carcinoembryonic antigen occur in 
patients with cholelithiasis,  alcoholic and chronic active hepatitis,  diverticulitis, 
pancreatitis, renal failure and fibrocystic breast disease and in patients who smoke. 
This lack of specificity precludes carcinoembryonic antigen assays as a screening 
test. The preoperative concentration of carcinoembryonic antigen has prognositc 
importance  and  has  been  shown  to  correlate  with  the  size  and  degree  of 
differentiation of carcinomas of the colon and rectum. Combined data from several 
large series have indicated that an elevated preoperative carcinoembiyonic antigen 
concentration correlated with poorer survival patients with carcinoma of the colon 
and  rectum,  independent  of  the  stage  of  disease  at  diagnosis.  After  curative 
resection, the Carcinoembryonic antigen concentration usually returns to normal 
within one month. A persistently elevated concentration implies residual disease.
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CLINICAL APPLICATIONS FOR MOLECULAR 
MARKERS TN COLORECTAL CARCINOMA
SCREENING:
Molecular analysis of endoscopic biopsies.
Identification of high — risk allelotypic change
Use of proliferative markers (ornithine decarboxylase) to indentify preneoplastic 
change.
DIAGNOSIS:
Molecular analysis  to identify risk factor for  invasion and metastases to select 
aggressive surgery for polyps or aggressive adjuvant therapy for carcinoma.
Intra operative immuno detection to identify occult metastases and guide surgery.
POST OPERATIVE FOLLOW UP:
Serial scanning with mixed monoclonal products.
TREATMENT:
Pharmacologic manipulation of signal transduction and surface molecules.
Monoclonal derived immunothrapy or chemotherapy.
Active immunotherapy utilizing tumour specific antigens.
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BIOCHEMICAL MARKERS
In the last decade, the molecular biologist have revolutionized the understanding 
of  the  genetic  mechanisms of  carcinogenesis  and our ability  to  manipulate  the 
genome. The immunobiologist  have been able to develop the means by which 
onco developmental antigens, unmasked by genetic events can form detection to 
management of metastatic disease these development will effect change in clinical 
practice (Passaro E)25.
At the screening level, use of molecular analysis may detect in early life those 
individuals  who  carry  genetic  defect.  Searching  for  individuals  who  are 
hemizygous for tumour suppressor genes may identify a population at high risk. 
Use of mucosal proliferative markers such as polyamine metabolic enzymes such 
as  ornithine  decarboxylase  from normal  mucosa  may identify  individuals  who 
already show expansion of the proliferate compartment.
Analysis  of  tumor  tissues  by  the  same  molecular  techniques  may  provide 
important prognostic information. The loss of the DCC locus, the appearance of 
surface CEA or increased amounts of plasminogen activators such as urokinase 
may identify the biologically more aggressive tumor This information may incline 
the surgeon to recommend resection for dysplastic polyp or select candidates more 
accurately for adjuvant chemotherapy.
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TUMOUR PLOIDY:
The technology exists to analyse DNA from small biopsy specimens of tumours 
using flow cytometry. Ploidy may correlate with the clinical behavior of the tumor. 
Tumours in early Astler — coller stage tended to be non deployed Aneuploidy is 
an  independent  predictor  of  recurrent  disease.  Other  investigation  have 
demonstrated  that  the  ploidy  status  is  of  equal  or  greater  importance  as  a 
prognostic  indicator  than  the  pathologic  stage  of  the  lesion.  Ploidy  may  have 
carcinoma;  however  its  exact  role  will  need  to  be  studied  as  it  becomes  a 
prognostic cariable in therapeutic trials.
EVALUATION OF SYNCHRONOUS LESIONS:
The incidence of synchronous carcinoma has been reported to be between 2% and 
7  and  the  incidence  of  synchronous  benign  polyposis  12%  to  62%.  Before 
resection total colonic evaluation should be performed to detect the presence of a 
synchronous  lesion.  Colonoscopy  is  the  preferred  method  for  this  evaluation. 
Synchronous polyps may be excised. In a review of 389 patients. It has been found 
that  one  half  of  the  syn;hronous  carcinomas  found  by  colonoscopy  were  not 
detected by barium enema examination and more than half of these carcinomas 
would not have been included in the planned resection. Because it provides the 
opportunity to remove synchronous polyps outside the planned area of resection, 
preoperative colonoscopy in patients with coloreetal carcinoma is favored.
If colonoscopy is unavailable, flexible sigmoidoscopy and double contrast barium 
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enema study should be performed. Most authors believe that air contrast enemas 
are  more sensitive  in  detecting  carcinoma of  the  colon however  Johnson et  al 
found no difference in either the rate of error or the ability to find lesions in an 
earlier stage when the results of barium enema study and a double
— contrast barium enema study were compared.
ASSESSMENT OF CARCINOMA OF RECTUM:
Most patients with carcinoma in proximal or distal location can undergo sphincter 
saving procedure with resection of the lesion and restoration of bowel continuity 
for patients with carcinoma in a distal rectal location, therapeutic options are based 
on  preoperative  assessment  of  the  lesion.  Favorable  localized  lesions  can  be 
treated with either local excision or fulguration. Thus, abdomino
— perineal resection and a permanent stoma can be avoided by accurate evolution 
including the size of the lesion, extent of circumferential involvement, degree of 
differentiation and depth of invasion. Methods of preoperative assessment include 
the use of digital rectal examination proctoscopy and intra rectal ultra sonography 
and other imaging techniques.
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DIGITAL RECTAL EXAMINATION
• Most important clinical examination
• 75% rectal cancers are palpable
• Exact  length  from  anal  verge,  nature  of  lesion,  extent  ,circumference 
,mobility and fixity to surrounding structures
• Growth in redundant sigmoid colon
• Pelvic deposits of proximal colon
ENDOSCOPIC ULTRASONOGRAPHY
• Endorectal USG
• Best study in distal 12cm of rectum
• High frequency probe 10MHz is used
• T staging very accurate
• T2- T3 differentiation is more accurate
• Nodal pickup rate is 59% PREVENTION OF SEPSIS:
Factors that have an important impact and reduce the changes of postoperative 
sepsis and leakage are
- Prophylactic antibiotics
- Mechanical bowel preparation
- Surgical technique like rapidity of operation exquisite and gentle handling of 
tissue.  Techniques  of  suturing  and  anastomosis  and  complete  hemostasis  and 
avoidance of dead space.
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• Site, size& location of the lesion
• Noncontrast -Hypodense lesion
• Contrast - Hypodense or isodense
• Lymphnodes—sensitivity increases when size> 1 cm
MRI
Indeterminate liver lesion on CT
• Rectal lesion
• Endorectal, pelvic coil - improve pick up rate
• Endorectal coil - accurate T staging
PREPARATION OF THE BOWEL:
Two techniques for accomplishing a surgery of “Near clean Category” has evolved 
with  one  there  was  mechanical  cleaning  of  the  bowel  with  other  various 
antimicrobial agent were given to sterilize the gut.
PROPHYLACTIC ANTIBIOTICS:
Mechanical preparation does not remove from the colon all the bacteria. For this 
reason many surgeons used to give a non — absorbable antibiotic for a few days 
prior to operation. There is conclusive evidence that the use of prophylactic broad 
spectrum antibiotics effective against  both aerobic and anaerobic organism can 
significantly reduce the risk of subsequent wound infection. The most commonly 
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used combinations are metronidazole and aminoglycoside or cephalosporin. The 
drugs would be given with the  premedication or at  the  anesthetic  induction in 
order to achieve the maximum tissue concentration at the cefuroxime 750 mgs 
plus metranidazole 500mg 1 hour prior to surgery plus another two doses of each 
Drug at 6 and 12 Hrs After surgery.
There is little doubt that good mechanical cleansing of the bowel is of 
considerable value. Traditionally this has been achieved by placing the patient on 
a liquid or elemental diet for 2-3 days followed by the administration of a 
cathartic agent. Nowadays a modified technique involves the use of polyethylene 
glycol (peglec solution) which can be drunk or administered by a nasogastic tube 
24 hours preceding the planned procedure. This can however ‘lead to potassium 
loss which may be severe in the elderly patient who are already on diuretics and 
requires up to date electrolyte estimation prior to operation. Adequate mechanical 
preparation may not be possible in those patients with an obstructing lesion or 
those patients coming to emergency surgery. On table lavage of the colon 
proximal to the obstruction using the appendix stump as a portal entry can be very 
effective and permits primary anastomosis to be performed more safely.
Involves complete resection of the rectum, mesorectum, levator muscles and anus with 
formation of a permanent colostomy. Rectal cancer involving levator muscle or anal 
sphincter are best managed by APR
TME (Total Mesorectal Excision)
• Should be performed in all cases done with curative potential
• Basis: high incidence of nodal involvement in rectal cancers
• Reduces the local recurrence rate
SPHINCTER SAVING PROCEDURES
• Low Anterior Resection- Colorectal Anastomosis.
• Extended Low Anterior Resection- Coloanal Anastomosis.
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• Local Excision.
• Ablative therapies.
OPTIONS ACCORDING TO THE SITE:
• Upper Rectum — Anterior Resection- Colorectal Anastomosis.
• Middle Rectum — Low Anterior Resection- Colorectal Anastomosis.
• Lower  Rectum  —  Extended  Low  Anterior  Resection-  Coloanal 
Anastomosis.
LOCAL EXCISION
• Highly selected patients (only 10% suitable)
• Patients refusing surgery/colostomy.
• Patients medically unfit for Major surgery.
• Local palliation.
BASIS OF LOCAL EXCISION
• To decrease chances of Local recurrence.
• To exclude patients with N +ve disease.
LOCATION OF THE TUMOR
• 6-8 cm from anal verge — Transanal Approach.
• Middle  1/3  rectum  —  Transanal  Endoscopic  Microsurgery  or  Posterior 
Approach.
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Upper 1/3 rectum
Full thickness excision Risk of Fecal
    not possible    spillage
SIZE
• Should be <3 cm.
• Should not occupy> 1/3 of circumference.
GRADE
• Only Well (or) Moderately differentiated tumors
PREOPERATVE EVALUATION
• Clinical examination is most crucial.
• Endorectal USG is a MUST
To assess T stage To exclude N +ve
       Accurately      Disease
• MRI, with Endorectal coil. 
APPROACH
TRANSANAL
• Transanal Excision.
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• Transanal Endoscopic Microsurgery.
POSTERIOR APPROACH
• Trans-Sacral — Kraske’s
• Trans-Sphincteñc — York Mason’s 
TRANSANAL APPROACH
• Commonly used.
• Suitable for Lower third lesions.
• Good lighting and retraction essential.
TRANSANAL ENDOSCOPIC MICROSURGERY
• Carbondioxide insufflation via 40 mm operating Rectoscope.
• X 6 magnification.
• Specialized Endoscopic instruments.
TRANS-SACRAL - KRASKE’S
For Middle third rectal lesions.
Coccyx and Lower two segments of Sacrum excised.
Increased risk of fecal fistula.
SPHINCTERIC - YORK MASON’S
No Sacrectomy.
Sphincteric complex carefully delineated,divided and reapproximated.
Decreased risk of fecal fistula.
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Increased risk of incontinence.
ECTROCOAGULATION LASER
Patients refusing surgery/colostomy.
Patients medically unfit for Major surgery.
Same selection criteria.
Great care in Anterior lesions.
Disadvt:Absence of pathology,multiple sessions.
ENDOCAVITARY RT - PAPILLION’S
Direct contact irradiation with Cone.
Tumor doses of 10,000- 12,000 cGy reached.
3 - 4 sittings over 8 wks with 2 wk intervals.
Mucosal necrosis.
Can be combined with EBRT for T2 lesions.
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REVIEW OF LITERATURE
Initial  results from a European  prospective randomized trial   with 
preoperative external radiation suggested that reduction in local recurrence, 
but no change in long-term survival, could be achieved.
            Later reports from the University of Florida showed not only marked 
reduction in local recurrence but also improved long term survival.
            In a extensive study by Kodner IJ, ( Ann Surg1989; 209(2):194 ) 
using preoperative external radiation therapy ,no complications have been 
attributed to the use of radiation therapy. In partcular, no colostomis have 
been  needed  and  no  leaked  anastomoses  have  occurred  that  could  be 
attributed  to  the  radiation.  One  component  of  the  anastomosis,  however, 
must not have been irradiated, this is accomplished by resecting the entire 
sigmoid colon and using descending colon for the proximal component of 
the anastomosis of for the colostomy.    
Rectal cancers that are suspected of being deeply invasive but are not 
significantly  tethered to  the surrounding tissue  and are  not  histologically 
poorly differentiated receive 2000cGy of external radiation during a 5 day 
period and are then resected early the following week. Those cancers that are 
even  more  aggressive,  in  that  they  are  poorly  differentiated  or  are 
significantly fixed to the surrounding tissue are treated with a regime that 
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not only controls  tumor deposits  in the pararectal  tissue,  but  also allows 
tumor shrinkage and increases the chances of definitive resectability. This 
regimen  consists  of  4500cGy  administered  during  a  5  week  period  (2 
treatments), a 6 to7 week waiting period, and then resection. This regimen 
allows maximum tumor shrinkage, without waiting so long that the cancer 
cells begin to repopulate. It  is  also chosen, as a schedule that allows the 
acute inflammatory changes of the radiation to subside,  yet it allows the 
surgery to be performed before the chronic fibrotic change of the radiation 
occur. The long term results of this series show that the use of combined 
preoperative external radiation followed by definitive surgery significantly 
increases  the  long-term  survival  as  compared  to  many  reports  in  the 
literature, and local recurrence of rectal cancer essentially was eliminated.
Of most interest was the fact that the survival of Duke’s B & C lesions 
was  very  similar,  perhaps  indicating  that  if  this  modality  is  used,  the 
importance of determining lymph node involvement pretreatment becomes 
les critical. The statistics also revealed that the 2000-cGy regimen was very 
effective and could be used for invasive cancers, unless the tumor is fixed, 
poorly differentiated, or extremely large.
The study concluded that preoperative radiation therapy controls the 
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cancer  at  the  peripheral  or  tangential  margin  of  resection,  and  that  it 
destroyed tumor deposits in  pararectal lymph nodes. The series has been 
ongoing  for  15  years.  Analysis  of  all  variables  showed  histologic 
differentiation and fixation to be of importance. In particular lymph node 
involvement was not a major variable. Therefore , if preoperative radiation 
therapy is used, a clinical staging system may become possible.
Rosanna  Berardi, Elena macaroni, azzurra onofri, university of italy, 
showed  that  multimodality  treatment  have  improved   the  prognosis  of 
locally advanced rectal cancer with local recurrence decreases from 40% to 
<10%, and overall survival improving from 50% to 75% in the last 40 years.
 National  research council  (NRC),  of the United Kingdom and the 
National  cancer  Institute  of  Canada  (NCIC)  analysed  a  7  year  trial  and 
shown that short-term preoperative radiation (25 Gy over 5 days ) results 
ibnnn a significant reduction in the local recurrence rate and disease-free 
survival for all stages of rectal cancer. 
47
PRE OP / POST OP RT
Pre op RT Post op RT
Sphincter preservation 39% 19%
Local failure 7% 11%
Acute toxicity 2.7% 8.5%
Diagnostic schema for restaging
• Clinical examination  
• Endoscopy
• Pelvic, abdomen CT or MRI (comparable with previous scan)
• Endosonography (comparable)
Methods of down-staging evaluation
• Pooling of whole data
• Matching of both data, before Neoadjuvant, before surgery
• Assessment of down-staging, outlining indicatively percentages of 
tumor volumetric reduction: > 50%, 30-40%, 20-30%, <10%.
• Survey of surgical procedures related to achieved down-staging
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Table 1. Results of trials comparing surgery vs. neoadjuvant therapy
Surgery    Rt+Surgery
Stockolm II Trial (S) (1996) (9)        56% 62%
Swedish Trial (S) (1997) (7)           48% 58%
EORTC (L) (1988)                      49% 52%
MRCRCWP (L) (1996)(16)             46% 52%
(RT alone; S: Short Term; L: Long term)
Comparisons study   
Surgery Surgery+RT
Surgery+RT+ 
chemotherapy
Local failure 25% 20% 10%
Disease free survival 65% 50% 45%
5 yr survival 45% 33% 26%
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MATERIAL AND METHODS
This study has been conducted in the Department of Surgery, Govt. 
Rajaji  hospital,  Madurai  during  2008-2009.  Patients  admitted  in  general 
surgery  units,  surgical  gastroenterology  &  surgical  oncology  department 
were selected. All these patients were subjected to detailed history, thorough 
clinical  examination  of  the  abdomen,  digital  rectal  examination, 
proctoscopy,  and  scopy  guided  biopsy  was  taken  for  Histopathological 
examination.
All  these patient  had base  line  biochemical  investigation done and 
included  Blood-  Hb%, TC,  DC,  sugar,  urea,  creatinine,   Urine – sugar, 
albumin, microscopy Liver function test Ultrasonography  Double contrast 
Barium enema  when  warranted  Computed  Tomogram plain  and  contrast 
enhanced, Magnetic Resonance Imaging when feasible.
All patients were counselled with regards to treatment side effects, 
possible outcome with and without the preoperative chemo-radiotherapy, the 
side effects during the course. The patients were counselled with regards to 
Colostomy.  During  the  counselling  session,  a  previous  Ostomate  was 
included.
Indications for neoadjuvant therapy, basing a difference between the 
absolute and relative one were explained.
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Dosages of drugs and radiation were taken care.
Comparing  indicatively  of  clinical  and  diagnostic  data  before 
neoadjuvant therapy and before surgery was done.
Patients  were  staged  according  to  the  TNM  classification  system 
using clinical and radiological data.
RADIATION THERAPY
The main reasons for favouring pre-operative radiation have been the 
desire  to  reduce  their  rate  of  both  pelvic  recurrence  and  extra  pelvic 
metastases based on the assumption that some metastases arise from cells 
released  during  intra  operative  manipulation  of  the  cancer,  the  lower 
likelihood of late radiation enteritis because small bowel is less likely to be 
adherent  in  the  pelvis  prior  to  surgery,&  the  relatively  greater  radio 
responsiveness  of  normally  oxygenated  cancer  cells  relative  to  cells  and 
tissues that may be hypoxic secondary to alteration in vascularity resulting 
from pelvic surgery.  
Radiotherapy guidelines
Anal  verge  ,dentate  line/  sphincter  –identified  by  radio  opaque 
markers & rectal contrast.
Balance between adequate distal coverage &minimal RT to sphincter.
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AP & PA fields –lateral border –pelvic side wall
Lateral field – superior & inferior margin
Post  border-  includes  presacral  soft  tissue  so  field  covers  anterior 
border  of  sacrum with  at  least  1.5  cm margin  for  motion  & dosimetric 
variation. 
Anterior border of lat field –cover post border of vagina & prostate, 
anterior extent of tumor & anterior edge or sacral promontory
Chemotherapy
5-fluorouracil (5-FU)- Antimetabolite ,it’s a pyrimidine antagonists is 
converted  in  the  body  to  the  corresponding  nucleotide  5-fluoro-2-
deoxyuridine  monophosphate,  which  inhibits  thymidylate  synthase  and 
blocks  the  conversion  of  deoxyuridic  acid  to  deoxythymidylic  acid. 
Selective  failure  of  DNA  synthesis  occurs  due  to  non  availability  of 
thmidylate. Thymidine can partially reverse its toxicity. Fluorouracil itself 
get incorporated into nucleic acid and this may contribute to it toxicity. Even 
resting  cell  are  affected,  though  rapidly  multiplying  ones  are  more 
susceptible. 
Efforts  have  been  made  to  enhance  the  activity  o  5-FU  by  co-
administration with other agent. The potency of 5-FU can be enhanced by 
the administration of reduced folate- LEUCOVORIN  when 5-FU is given in 
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combination  with  leucovorin  response  rates  range  from 21% to  48%.  A 
randomized  prospective  trail  compared  5-FU  alone,  sequentially 
methotrexate  plus  5-FU  and  leucovorin  plus  5FU  among  patients  with 
untreated  colorectal  cancer.  Response  rates  of  11%,5%  and  49.8% 
respectively were achieved. 
The side effects associated with the regimen of 5-FU plus leucovorin 
are similar  to those of  5-FU alone although the severity  may be greater. 
Patients  may  develop  severe  diarrhoea  or  mucositis.  Hospitalization  for 
intravenous hydration occasionally needed. 
All  patients  in  the  study,  after  thorough  clinical,  radiological, 
histopathological  and  baseline  investigation  and  counselling  underwent 
radiotherapy 4500 to 6000cGy in 150 to 200cGy fractions for 5 days a week 
and concurrent 5-FU 10mg/kg and leucovorin 30mg infusion every 21 days 
for 6 cycles and restaged after the completion of the therapy clinically and 
radiologically.
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RESULTS
Total Number of cases studied     - 20  
Total Number of male patients     - 14
Total Number of female patients   - 06
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The distribution of cases according to their histopathology
• Well differentiate adenocarcinoma   -  4 - 20%
• Moderately differentiated 
                              adenocarcinoma    -  8 - 40%
   poorly differentiated adenocarcinoma -5 - 25%
   infiltrating type of adenocarcinoma    - 2 - 10%
   mucinous adenocarcinoma               - 1 - 5%
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Distance of lower extent of lesion from the anal verge 
pre-CRT    post-CRT
4 to 6cm             +7 3
6 to 8cm           -5 6
8 to 12cm         -6 8
12 to 15cm         -1 2
More than 15cm -1 1
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Type of surgery done  following neo adjuvant therapy
Sl. No Surgery No. of patients Percentage
1. Low anterior resection 4 20%
2. Anterior resection 7 35%
3. APR 7 35%
4.  Loop colostomy 2 10%
Type of Surgery Done following neo adjuvant 
therapy
35%
35%
10% 20%
Low anterior resection Anterior resection APR Loop colostomy
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DISCUSSION
Rectal malignancy is one among the common malignancy presenting 
at GRH, Madurai.
The  reason  for  which  most  patients  seek  medical  attention  was 
Bleeding Per Rectum.
40% of the patients had moderately differentiated
25% of them had poorly differentiated anenocarcinoma
20% of the patients had well differentiated anenocarcinoma
10% of the patients had invasive differentiated anenocarcinoma
5% of the patients had mucinous differentiated anenocarcinoma
90%  of  the  patients  underwent  definitive  surgery,  while  Jetekog 
reported 85.6%
Abdomino  perineal  resection  and  anterior  resection  was  the 
commonest surgery performed in the study constituting about 70%.
55% of total patients had undergone a spincter preserved procedure.
In  35%  of  patients,  tumor  regression  of  ≥2cm,  ≤3cm  was  noted 
followed neoadjuvant therapy on Digital Rectal examination.
All  patients  were  subjected  to  chemo-radiotherapy  for  6weeks, 
followed by surgery. 20% of the patients underwent Low Anterior Resection, 
35%  of  patients  underwent  Anterior  Resection,  35%  of  the  patients 
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underwent  Abdomino-Perineal  Resection,  10%  had  undergone  Loop 
Colostomy.
Total number of patients who underwent APR was 35% which without 
The Neo-Adjuvant therapy would have been 60% i.e.,  25% patients were 
benefited from a sphincter saving procedure
Out of the 20 patients 2 female patients had posterior vaginal wall 
fixity  which  following  CRT  underwent  APR  with  out  resection  of  the 
posterior vaginal wall.
The reason for inoperability in the study was anteriorly bladder  fixity.
Mobidity
Among  7  patients  who  underwent  APR,  4  patients  (55.5%)  had 
perineal wound infection, which was treated with appropriate dressing and 
antibiotics after obtaining culture and sensitivity reports.
Out  of  18  patients,  who  underwent  definitive  surgery  6  patients 
constituting 33.33% had abdominal wound infection and were treated with 
daily dressing and appropriate antibiotics.
Mortality – 10%
2 patients had died post-operatively, one patient on Ist POD due to 
Pulmonary Embolism and the other on 8th POD due to ARDS.
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CONCLUSION
Goals  of  Neoadjuvant  are  varied  ,has  advantages  over  adjuvant 
therapy  Neoadjuvant  therapy  may  be  considered  a  rational  approach  for 
treatment of curative Rectal cancer.
Volumetric  reduction  of  neoplasia,  mesorectum  and  lateral  pelvic 
nodes was evident in 90% of the patients
There was 25% improved surgical  feasablity for a sphincter saving 
procedure in the study.
There was a definite reduction of side effect on close organ, mainly on 
small  bowel,  which  are  not  displaced  into  pelvis  by  post-operative 
adhesions.
There  was  no  local  recurrence  in  patients  who underwent  surgery 
during the 2 year follow up period
All  Non-Metastatic  patients  are  candidates  for  pre  operative 
neoadjuvant therapy.
Patient selection by detailed pre-op staging very important.
 Radiation total dose/fraction/fields are not uniformly agreed upon.
Neoadjuvant  therapy needed in many cases.
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PROFORMA
Name CRT  –  Regime  &  Date  of  staring 
therapy 
Age/sex
I.P. No. D.O.S.
D.O.A.
DRE – Pre  CRT, Post CRT 
USG
Colonoscopy
CT
MRI  
(Optional)  
Biopsy   
Histopathological Report 
Investigations 
Hb%, TC, DC
Blood grouping 
Urine 
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Sugar 
Albumin 
Microscopy  Sugar 
Urea 
S.creatinine 
Blood 
Stool for occult blood
X ray chest
ECG
Surgical Procedure  
Operative findings 
Post operative follow up 
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ABBREVIATIONS
APR - Abdomino Perineal Resection
AR - Anterior Resection 
LAR - Low Anterior Resection
Pre CRT - Pre-Chemo Radiotherapy 
Post CRT - Post-Chemo Radiotherapy
Mod. Diff - Moderately Differentiated 
PD - Poorly Differentiated 
WD - Well differentiated 
MAC - Mucinous adenocarcinoma 
IC - Infiltrating adenocarcinoma 
PLC - Palliative loop colostomy 
CM - Centimeter
Sx - Surgery done  
DOS - Date of Surgery 
NP - Not palpable 
DRE - Digital Rectal Examination  
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